Prescribing Changes (v6.71.2 Enhancement)
A change in the National Health (Pharmaceutical Benefits) Regulations means that from 1st Feb 2021, all PBS/RPBS prescriptions will require the inclusion of active ingredient name(s)
A brand should be included only if the prescriber deems it to be clinically appropriate and when the brand name is included, the active ingredient(s) must appear first.
It is also part of wider government activity to improve consumer awareness and recognition of the active ingredients in their medicines.
The Full MIMS Full Prescribing Information is now updated,
Example: The old version of MIMF Full Prescribing Information was ;
Its been now updated to a more detailed view ;
This change will also reflect in the way the drugs are getting printed.
As per the new legislation, the prescription should include the brand name and the active ingredient.
Eg: Drug: Lamictal 50mg
Brand name: Lamictal Chewable tablets
Active ingredient : Lamotrigine
Another change is the inclusion of a new field 'Include Brand Name on Script' - A new checkbox is added when prescribing a drug allow doctors to include brand name on the script.
This checkbox will be checked by default if the user has selected brand substitution not permitted as the brand is necessary to dispense script.
